Opioid drugs in maintenance and detoxification treatment of opiate addiction; Substance Abuse and Mental Health Services Administration, HHS.  Final rule.
The Department of Health and Human Services and the Substance Abuse and Mental Health Services Administration (SAMHSA) are issuing final regulations for the use of narcotic drugs in maintenance and detoxification treatment of opioid addiction.  This final rule repeals the existing narcotic treatment regulations enforced by the Food and Drug Administration (FDA), and creates a new regulatory system based on an accreditation model.  In addition, this final rule shifts administrative responsibility and oversight from FDA to SAMHSA.  This rulemaking initiative follows a study by the Institute of Medicine (IOM) and reflects recommendations by the IOM and several other entities to improve opioid addiction treatment by allowing for increased medical judgment in treatment.
D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000534:rehabilitation; D012046:Rehabilitation / Q000331:legislation & jurisprudence; D014481:United States; D014482:United States Substance Abuse and Mental Health Services Administration
D009292:Narcotic Antagonists; D008691:Methadone